(CercleFinance.com) – Ipsen Pharma declared to the AMF that it crossed the thresholds of 5% of the capital and voting rights of Genfit on December 22, 2021, and held 8% of the capital and 7.64 % of the voting rights of this company.
This crossing of thresholds results from the subscription to a reserved capital increase of the company Genfit.